Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Prostate cancer screening breakthrough could cut time of test to twenty minutes - One in eight men will be diagnosed with ...

Mr Hearn, president of the Professional Darts Corporation (PDC), said an awareness campaign about the disease had given him ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

Vir Biotechnology shares were up 67% to $13.15 after the company reported encouraging initial Phase 1 data for its dual-masked T-cell engagers, VIR-5818 and VIR-5500. The clinical-stage ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

Discover a study where results from the 2,129 participants revealed that Stockholm3 demonstrated non-inferior sensitivity ...